Metagenomi, Inc. Common Stock (MGX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.71
+0.55%
Mkt Cap $60.07M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $7.33M | $3.91M | -46.64% | -$0.58 | -$0.60 | -3.45% |
| Q4 2025 Nov 11, 2025 | $7.82M | $8.66M | +10.69% | -$0.60 | -$0.55 | +8.33% |
| Q3 2025 Aug 12, 2025 | $7.94M | $8.51M | +7.22% | -$0.68 | -$0.54 | +20.59% |
| Q2 2025 May 13, 2025 | $8.30M | $4.13M | -50.28% | -$0.62 | -$0.68 | -9.68% |
| Q1 2025 Mar 17, 2025 | $9.23M | $9.61M | +4.15% | -$0.62 | -$0.63 | -1.61% |
| Q4 2024 Nov 13, 2024 | $6.76M | $11.51M | +70.35% | -$0.70 | -$0.45 | +35.71% |
| Q3 2024 Aug 14, 2024 | $12.65M | $20.01M | +58.17% | -$0.59 | -$0.29 | +50.85% |
| Q2 2024 May 14, 2024 | $7.86M | $11.16M | +42.02% | -$0.95 | -$1.19 | -25.26% |
| Q1 2024 Feb 10, 2024 | $11.60M | $12.40M | +6.89% | -$2.04 | -$0.51 | +74.76% |
| Q3 2023 Sep 30, 2023 | — | $12.36M | — | — | -$0.53 | — |
| Q2 2023 Jun 30, 2023 | — | $11.34M | — | — | -$0.35 | — |
| Q1 2023 Mar 31, 2023 | — | $8.66M | — | — | -$0.54 | — |
| Q4 2022 Dec 31, 2022 | — | $5.59M | — | — | -$0.39 | — |
| Q3 2022 Sep 29, 2022 | — | $4.91M | — | — | -$0.28 | — |
| Q2 2022 Jun 30, 2022 | — | $3.35M | — | — | -$1.57 | — |
| Q1 2022 Mar 31, 2022 | — | $3.35M | — | — | -$1.57 | — |